Healthy Skepticism Library item: 14518
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
de Wildt G, Khoon CC.
Patents or patients? Global access to pharmaceuticals and social justice
Med Confl Surviv. 2008 Apr; 24:(Suppl 1):S52-61
http://www.ncbi.nlm.nih.gov/pubmed/18771195
Abstract:
Innovation, vaccine development, and world-wide equitable access to necessary pharmaceuticals are hindered by current patenting arrangements and the orientation of pharmaceutical research. Plausible alternatives exist, including instituting the right of national or international agencies to act in the public interest and to buy patents selectively with a view to innovation and equitable access. Alternatives could partly or wholly finance themselves and lower pharmaceutical prices globally. Countries, individuals or groups of patients could help promote alternatives by calling into question the current emphasis on commercialization and profit, and by demanding globally equitable arrangements when sharing data that are important for research or when individuals or communities volunteer as research participants.
Keywords:
MeSH Terms:
Biomedical Research/economics*
Drug Industry/economics*
Health Knowledge, Attitudes, Practice
Health Services Accessibility/economics*
Humans
Intellectual Property*
Pharmaceutical Preparations/economics*
Social Class
Social Justice/economics*
Socioeconomic Factors
World Health*
Substances:
Pharmaceutical Preparations
